A SAFE delays the pricing conversation, but the valuation cap often ends up being the price anyway. Carta’s Q3 2026 US data confirms it: among companies that went on to raise a seed round, most SAFEs converted at their cap. Seed valuations typically land above the cap, which means the cap is what the investor actually paid.
The practical takeaway for founders is to treat cap negotiations the same way you’d treat a priced round. If you’re inclined to anchor high and negotiate down, do it at the cap stage, not later.
What the data shows
- Most SAFEs converted at their valuation cap among companies that subsequently raised seed rounds
- Median caps rose across every round size
- Total pre-seed dollars grew over the period
- The number of pre-seed deals fell
More money concentrated in fewer deals is the pattern here. Investors are writing larger checks into a smaller set of companies rather than spreading smaller bets across a wider field.
The operator implication
If you’re raising on a SAFE right now, the cap you agree to is likely the effective price your early investors pay. That matters when you get to your Series A and start calculating dilution. Set the cap with the same care you’d bring to a priced round term sheet.
